Samlyn Capital, LLC 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:43 pm Sale |
2022-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Samlyn Capital, LLC | 0 0.000% |
-2,570,292 (Position Closed) |
Filing |
| 2022-02-25 5:02 pm Purchase |
2022-02-15 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Samlyn Capital, LLC | 2,570,292 8.200% |
800,438 (+45.23%) |
Filing |
| 2022-02-14 2:11 pm Purchase |
2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Samlyn Capital, LLC | 1,769,854 5.600% |
1,769,854 (New Position) |
Filing |